The multidimensional role of Platelet-Related factors in the occurrence and development of colorectal cancer.
Platelets, traditionally recognized as core components of the coagulation system, have emerged as critical regulators in the multistep progression of colorectal cancer (CRC) beyond their hemostatic functions. Accumulating evidence demonstrates that platelets orchestrate a multidimensional network to promote CRC initiation, proliferation, invasion, metastasis, and immune escape through direct interactions with tumor cells, modulation of the tumor microenvironment, and regulation of angiogenic processes. Two key platelet surface molecules, P-selectin (CD62P) and C-type lectin-like receptor-2 (CLEC- 2), serve as central hubs in these pro-tumorigenic cascades: CD62P mediates platelet-tumor cell aggregation, extravasation, and immunosuppressive macrophage polarization, while CLEC-2 interacts with its ligand podoplanin (PDPN) to drive platelet activation, tumor cell epithelial-mesenchymal transition, and cancer-associated thrombosis. In-depth research into their mechanisms of action is of great significance for the development of targeted therapeutic drugs for colorectal cancer.
Authors
- Yuyu Chen (ORCID: https://orcid.org/0000-0002-5974-3672)
- Haobo Zhang (ORCID: https://orcid.org/0000-0002-8770-2034)
Institutions
- Central South University (CN)
- Hunan Cancer Hospital (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-18
- DOI
- https://doi.org/10.14670/hh-25-177
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00